Description
CJC-1295 without DAC is a synthetic modified peptide compound designed for laboratory research. This molecular variant lacks the Drug Affinity Complex (DAC) modification, resulting in different stability characteristics in experimental conditions. The compound features a precisely engineered 29-amino acid sequence structure, showing selective receptor binding properties in vitro studies. Without the DAC modification, this variant demonstrates different behavior in solution compared to its DAC-modified counterpart, making it suitable for specific types of controlled laboratory research and molecular signaling studies.
Drago Pharma Properties
| Chemical Formula | C152H252N44O42 |
| Synonyms | CJC1295 without DAC; Modified GRF (1-29) |
| Molar Mass | 3367.9 g/mol |
| CAS Number | 446262-90-4 |
| PubChem | 91976842 |
| Total Active Ingredient | 2mg per vial |
| Shelf Life | 36 months |
Drago Pharma Important Notice
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.
Note: These peptides are freeze-dried, a process that extends shelf life and preserves purity and integrity during storage. No fillers are used in this process.
There are no reviews yet.